News Gilead's next gen HIV prevention trial to begin in UK UK hospital seeking ethical clearance for trial of Gilead's new PReP drug.
News Academia, not pharma, worse at publishing trial findings Shire and BMS hailed as clinical trial transparency champions.
News Nissan stays in UK - but will Japanese pharma? Japanese R&D investment could follow EMA out of UK - experts.
News Big pharma could leave UK - AZ's Pangalos Last week saw the publication of the UK's Accelerated Access Review, containing proposals to cut four years from the drug development process – but AstraZeneca seems unconvinced that access
News ‘Organs-on-chips’ developer Emulate seeks drug testing revol... Extra funding brings series B financing round to $45 million total.
News Avacta hoping to disrupt antibody drug dominance Avacta is one of several biotechs turning their backs on mabs.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
